Vall d'Hebron Talks by VHIR 'Mucins in clear cell Renal Cell Carcinoma. STATing novel biomarkers and therapeutic strategies'

 Vall d'Hebron Talks by VHIR
  Sala de juntes de l'Edifici Central del VHIR (Planta 0) — See in map
04/06/2025
04/06/2025 -- From 12:00h to 13:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: In-person
Share it:

Speaker: Dr. Gerard Cantero-Recasens, Principal Investigator - Renal Physiopathology Group. Vall d’Hebron Institut de Recerca (VHIR)- Vall d’Hebron Barcelona Hospital Campus.

Abstract: Clear Cell Renal Cell Carcinoma (ccRCC) stands as the most prevalent and aggressive subtype of renal cell carcinoma, characterized by unfavourable prognosis. Commonly asymptomatic, approximately one-third of ccRCCs are diagnosed at metastatic stage, resulting in a 95% mortality rate. This underscores the urgent need for both early diagnostic tools and prognostic markers to predict disease progression and response to treatment. 

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.